Prognosis
Oxford Begins Study to Prevent Worsening of Mild Covid-19 Cases
- More than 500 doctors’ offices recruiting vulnerable, elderly
- Trial is first for Covid therapy in primary care, Oxford says
This article is for subscribers only.
Scientists from the University of Oxford are starting a first-of-its-kind study to see whether available drugs can help keep older, more vulnerable people with mild cases of Covid-19 from becoming severely ill.
More than 500 U.K. doctors’ offices are recruiting for the trial of drugs that are already approved for other purposes, such as the antimalarial hydroxychloroquine and antibiotics that are normally used against bacterial infections. Participants must be older than 65 or aged 50 to 64 with chronic illnesses such as diabetes or asthma.